<DOC>
	<DOCNO>NCT00147004</DOCNO>
	<brief_summary>The purpose study determine whether steroid decrease 28-day mortality patient septic shock .</brief_summary>
	<brief_title>Corticosteroid Therapy Septic Shock - Corticus</brief_title>
	<detailed_description>The use steroids septic shock remain controversial . The purpose study determine whether hydrocortisone decrease 28-day mortality patient septic shock . The primary end point 28-day mortality non-responders ACTH ( &lt; = 9 mcg/dl 250 nmol/L post ACTH ) . Secondary endpoint 28 day cause mortality total group responder , ICU hospital mortality , one year mortality , organ system failure reversal especially shock , duration ICU total hospitalisation . In double-blinded fashion ( randomized 1:1 basis ) , patient receive 50 mg intravenously every 6 hour 5 day . After 5 day , treatment taper 50 mg give intravenously every 12 hour day 6-8 , 50 mg every 24 hour day 9-11 , stop . All concomitant treatment , include antibiotic , fluid , vasopressor ancillary therapy give discretion primary care physician . Evidence-based guideline management severe sepsis septic shock International Sepsis Forum ( Intensive Care Med 2001 ; 27 : S124-S134 ) encourage follow . All serious adverse event ( SAE ) occur day 0 28 , unexpected and/or consider possibly probably relate study medication , must document report within 24 hour Safety Efficacy Monitoring Committee . Non-serious adverse event list case report form unexpected believe related study drug day 0 14 . Specific adverse event monitor closely relationship corticosteroid shock : 1 . Use corticosteroid , i.e . gastrointestinal bleeding superinfection ; hyperglycemia , hypernatremia , muscular weakness , etc . 2 . Shock use vasopressor , i.e . stroke , acute myocardial infarction peripheral ischemia . In addition , substudies include harmonization cortisol compare cortisol level measure local laboratory central laboratory , immune neuro-endocrine interaction , neuromuscular weakness cytokine .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>1 . Clinical evidence infection within previous 72 hour ( may present long 72 hour ) ( , b , c , 1 require ) 1 . Presence polymorphonuclear cell normally sterile body fluid ( exclude blood ) ; 2 . Culture Gram stain blood , sputum , urine normally sterile body fluid positive pathogenic microorganism ; 3 . Focus infection identify visual inspection ( e.g . rupture bowel presence free air bowel content abdomen find time surgery , wound purulent drainage ) ; 4 . Other clinical evidence infection treat community acquire pneumonia , purpura fulminans , necrotising fascitis , etc . 2 . Evidence systemic response infection define presence two follow sign within previous 24 hour . These sign may present long 72 hour . 1 . Fever ( temperature &gt; 38.3°C ) hypothermia ( rectal temperature &lt; 35.6°C ) ; 2 . Tachycardia ( heart rate &gt; 90 beat/min ) ; 3 . Tachypnea ( respiratory rate &gt; 20 breaths/min , PaC02 &lt; 32 mmHg ) patient require invasive mechanical ventilation ; 4 . Alteration WBC count &gt; 12,000 cells/mm3 , &lt; 4,000 cells/mm3 &gt; 10 % immature neutrophil ( band ) . 3 . Evidence shock define ( A + B require within previous 72 hour ( may NOT present longer 72 hour ) . A . A systolic blood pressure &lt; 90 mmHg decrease SBP 50 mmHg baseline previous hypertensive patient ( least one hour ) despite adequate fluid replacement OR need vasopressor least one hour ( infusion dopamine ≥ 5 mcg/kg/min dose adrenaline , noradrenaline , phenylephrine vasopressin ) maintain SBP ≥ 90 mmHg ; B. Hypoperfusion organ dysfunction result underlie disease drug , attributable sepsis , include one following : 1 . Sustained oliguria ( urine output &lt; 0.5 ml/kg/hr minimum 1 hour ) 2 . Metabolic acidosis [ pH &lt; 7.3 , base deficit &gt; = 5.0 mmol/L , increase lactic acid concentration ( &gt; 2 mmol/L ) ] . 3 . Arterial hypoxemia ( Pa02/FI02 &lt; 280 absence pneumonia ) ( Pa02/FI02 &lt; 200 presence pneumonia ) . 4 . Thrombocytopenia platelet count ≤ 100,000 cells/mm3 . 5 . Acute altered mental status ( Glasgow Coma Scale &lt; 14 acute change baseline ) . 4 . Informed Consent 5 . Cortisol level baseline 60 minute 0.25 mg cosyntropin 1 . Pregnancy 2 . Age less 18 . 3 . Underlying disease prognosis survival le 3 month . 4 . Cardiopulmonary resuscitation within 72 hour study . 5 . Druginduced immunosuppression , include chemotherapy radiation therapy within 4 week study . 6 . Administration chronic corticosteroid last 6 month acute steroid therapy ( dose ) within 4 week ( include inhale steroid ) . Topical steroid exclusion . 7 . HIV positivity . 8 . Presence advance directive withhold withdraw life sustain treatment ( i.e . DNR ) . 9 . Advanced cancer life expectancy le 3 month . 10 . Acute myocardial infarction pulmonary embolus . 11 . Another experimental drug study within last 30 day . 12 . Moribund patient likely die within 24 hour . 13 . Patients ICU 2 month time start septic shock .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Septic shock</keyword>
	<keyword>Steroids</keyword>
	<keyword>Hydrocortisone</keyword>
	<keyword>Mortality</keyword>
	<keyword>Reversal shock</keyword>
	<keyword>Adrenal insufficiency</keyword>
</DOC>